Literature DB >> 12150854

Synthesis of tumor-associated glycopeptide antigens.

Constanze Brocke1, Horst Kunz.   

Abstract

Carbohydrates and peptides linked together in glycoproteins constitute important components of the molecular communication between cells in multicellular organisms. Cell morphogenesis and tumorigenesis are accompanied by changes in the glycoprotein profiles of the outer cell membranes. Glycopeptide fragments of glycoproteins that have altered structures in tumor cells are of interest as tumor-associated antigens for the distinction between normal cells and tumor cells. In contrast to glycoproteins isolated from biological sources, synthetic glycopeptides are obtained in pure form and exactly specified structures. The methods developed for the synthesis of glycopeptides with tumor-associated antigen structure are outlined in this article by means of a series of typical examples. Beginning with O-glycopeptides of the relatively simple alpha-O-galactosamine-serine/threonine (T(N)-antigen) type, glycopeptide antigens of increasing complexity are described. The review includes syntheses of the saccharide components, the glycosylation reactions to furnish the O-glycosyl amino acid building blocks, their selective C- and N-terminal deprotection and the use of these building blocks for glycopeptide syntheses both in solution and on the solid support. Particular attention is given to glycopeptides containing sialic acid residues, whose syntheses are demanding since reversible protection of the sialic carboxylic group is required. Synthetic methods for the construction of N-glycopeptides carrying the important cell adhesion ligands sialyl Lewis x and sialyl Lewis a antigen are also described. Strategies for the construction of glycopeptides of this type require methods compatible with the presence of the sialic acid residue, as well as with the acid-sensitivity of the fucoside bonds.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150854     DOI: 10.1016/s0968-0896(02)00135-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  A high-throughput O-glycopeptide discovery platform for seromic profiling.

Authors:  Ola Blixt; Emiliano Cló; Aaron S Nudelman; Kasper Kildegaard Sørensen; Thomas Clausen; Hans H Wandall; Philip O Livingston; Henrik Clausen; Knud J Jensen
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

2.  Characterization of two UDP-Gal:GalNAc-diphosphate-lipid β1,3-galactosyltransferases WbwC from Escherichia coli serotypes O104 and O5.

Authors:  Shuo Wang; Diana Czuchry; Bin Liu; Anna N Vinnikova; Yin Gao; Jason Z Vlahakis; Walter A Szarek; Lei Wang; Lu Feng; Inka Brockhausen
Journal:  J Bacteriol       Date:  2014-06-23       Impact factor: 3.490

3.  Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.

Authors:  Elaheh Gheybi; Jafar Amani; Ali Hatef Salmanian; Farhad Mashayekhi; Samaneh Khodi
Journal:  Tumour Biol       Date:  2014-08-16

Review 4.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

5.  Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis.

Authors:  Emiliano Cló; Stjepan K Kracun; Aaron S Nudelman; Knud J Jensen; Jan-Åke Liljeqvist; Sigvard Olofsson; Tomas Bergström; Ola Blixt
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.

Authors:  Hamed Malekan; Gabriel Fung; Vireak Thon; Zahra Khedri; Hai Yu; Jingyao Qu; Yanhong Li; Li Ding; Kit S Lam; Xi Chen
Journal:  Bioorg Med Chem       Date:  2013-03-07       Impact factor: 3.641

Review 7.  Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.

Authors:  Danica P Galonić; David Y Gin
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

8.  MUC1 glycopeptide epitopes predicted by computational glycomics.

Authors:  Wei Song; Elizabeth S Delyria; Jieqing Chen; Wei Huang; Jun Soo Lee; Elizabeth A Mittendorf; Nuhad Ibrahim; Laszlo G Radvanyi; Yunsen Li; Hongzhou Lu; Huaxi Xu; Yinqiang Shi; Lai-Xi Wang; Jeremy A Ross; Silas P Rodrigues; Igor C Almeida; Xifeng Yang; Jin Qu; Nathaniel S Schocker; Katja Michael; Dapeng Zhou
Journal:  Int J Oncol       Date:  2012-09-27       Impact factor: 5.650

9.  A comparative study of recombinant and native frutalin binding to human prostate tissues.

Authors:  Carla Oliveira; José A Teixeira; Fernando Schmitt; Lucília Domingues
Journal:  BMC Biotechnol       Date:  2009-09-09       Impact factor: 2.563

10.  Synthesis and immunological evaluation of N-acyl modified Globo H derivatives as anticancer vaccine candidates.

Authors:  Canjia Zhai; Xiu-Jing Zheng; Chengcheng Song; Xin-Shan Ye
Journal:  RSC Med Chem       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.